Literature DB >> 9023384

Prognostic significance of TGF-alpha expression in breast cancer.

P K Auvinen1, P K Lipponen, V V Kataja, R T Johansson, K J Syrjänen.   

Abstract

A series of breast cancer biopsies from 204 women were analysed immunohistochemically for the expression of transforming growth factor alpha (TGF-alpha). Expression of TGF-alpha was intense in 119 cases (58%), weak in 63 (31%), and totally absent in 22 (11%) of the cases. No correlation was observed between the expression of TGF-alpha and tumour size, metastasis at diagnosis, histological type and grade, ER and PR status, DNA index, S-phase fraction or the expression of TGF-beta1 or beta2. However, the expression of TGF-alpha was significantly related to axillary lymph node metastasis and to low survival probability during the follow-up. These data support the earlier observations on the in vitro studies, suggesting that TGF-alpha most probably exerts an in vivo growth stimulation of female breast cancer cells.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 9023384     DOI: 10.3109/02841869609100717

Source DB:  PubMed          Journal:  Acta Oncol        ISSN: 0284-186X            Impact factor:   4.089


  7 in total

Review 1.  Transgenic models to study actions of prolactin in mammary neoplasia.

Authors:  Lisa M Arendt; Linda A Schuler
Journal:  J Mammary Gland Biol Neoplasia       Date:  2008-01-25       Impact factor: 2.673

Review 2.  Pre-clinical applications of transgenic mouse mammary cancer models.

Authors:  C J Kavanaugh; K V Desai; A Calvo; P H Brown; C Couldrey; R Lubet; J E Green
Journal:  Transgenic Res       Date:  2002-12       Impact factor: 2.788

3.  MicroRNA-374b inhibits breast cancer progression through regulating CCND1 and TGFA genes.

Authors:  Yan Liu; Ai Zhang; Ping-Ping Bao; Li Lin; Yina Wang; Haijian Wu; Xiao-Ou Shu; Aiguo Liu; Qiuyin Cai
Journal:  Carcinogenesis       Date:  2021-04-30       Impact factor: 4.944

4.  HIF1-alpha expressing cells induce a hypoxic-like response in neighbouring cancer cells.

Authors:  Hannah Harrison; Henry J Pegg; Jamie Thompson; Christian Bates; Paul Shore
Journal:  BMC Cancer       Date:  2018-06-20       Impact factor: 4.430

5.  TGFα-EGFR pathway in breast carcinogenesis, association with WWOX expression and estrogen activation.

Authors:  Karolina Pospiech; Magdalena Orzechowska; Magdalena Nowakowska; Dorota Anusewicz; Elżbieta Płuciennik; Katarzyna Kośla; Andrzej K Bednarek
Journal:  J Appl Genet       Date:  2022-03-15       Impact factor: 3.240

6.  Azithromycin and Ceftriaxone Differentially Activate NLRP3 in LPS Primed Cancer Cells.

Authors:  Gulcin Tezcan; Mohammad Alsaadi; Shaimaa Hamza; Ekaterina E Garanina; Ekaterina V Martynova; Gulshat R Ziganshina; Elina R Farukshina; Albert A Rizvanov; Svetlana F Khaiboullina
Journal:  Int J Mol Sci       Date:  2022-08-22       Impact factor: 6.208

7.  The TGFα-EGFR-Akt signaling axis plays a role in enhancing proinflammatory chemokines in triple-negative breast cancer cells.

Authors:  Rosa Mistica C Ignacio; Carla R Gibbs; Eun-Sook Lee; Deok-Soo Son
Journal:  Oncotarget       Date:  2018-06-29
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.